News | July 16, 2021
Jubilant Pharmova’s Roorkee facility placed under import alert
The company will engage with the agency to resolve the import alert at the earliest and ensure cGMP compliance.
The company will engage with the agency to resolve the import alert at the earliest and ensure cGMP compliance.
The company expects to see steady performance led by new launches and gradual normalization post the scale-up in vaccination
The roller coaster ride during the pandemic has taken Indian pharmaceutical industry through a lot of bitter sweet experiences.
Strides Pharma Science reported total income of Rs.3367.29 crores during FY 2020-21
The company reported net profit for FY21 at Rs. 2,903.8 crore, lower by 23% over last year
It reported total income of Rs.15299.25 crores during the FY ended March 31, 2021
R&D Centre will be housed in Baddi and will cater to all business divisions in addition to expansion plans for all its verticals including APls, Formulations and Medical Devices
Lonza's Ibex Design end-to-end offering will cover the development stages of IMT-009 from development candidates through early clinical studies
The company is pursuing specific goals in the areas of science and technology, value chain as well as climate and the environment.
The government has taken all the effective measures to make healthcare affordable
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
